CUC Inc.
Stock Price Chart
2026/10/09 12:26 UpdatedPrice Trend
2026/10/09 12:26 UpdatedPrice & Trading Details
2026/10/09 12:26 UpdatedPRICE
TRADING
Analyst Recommendations 1 analysts
Updated 2026/10/01Earnings Calendar
Updated 2026/10/01Recent Earnings
| Date | EPS Est. | EPS Actual | Surprise |
|---|---|---|---|
| 2026/07/29 | ¥7.28 | ¥-9.60 | -231.9% |
| 2026/04/29 | ¥46.30 | ¥48.48 | +4.7% |
| 2026/02/02 | ¥29.00 | ¥27.98 | -3.5% |
| 2025/11/10 | ¥29.74 | ¥13.79 | -53.6% |
Shareholder Composition
Updated 2026/10/01Financial Performance
2026/10/04 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥35,210M | ¥33,025M | ¥47,043M | ¥54,353M |
| Gross Profit | ¥13,776M | ¥15,923M | ¥23,172M | ¥25,413M |
| Operating Income | ¥3,683M | ¥3,736M | ¥5,343M | ¥5,782M |
| Pretax Income | ¥3,733M | ¥4,423M | ¥5,757M | ¥5,845M |
| Net Income | ¥2,423M | ¥2,595M | ¥3,131M | ¥2,854M |
| EPS | ¥113.91 | ¥93.99 | ¥106.81 | - |
| Operating Margin | 10.46% | 11.31% | 11.36% | 10.64% |
| Balance Sheet | ||||
| Total Assets | ¥39,750M | ¥62,836M | ¥85,167M | ¥98,054M |
| Total Equity | ¥11,704M | ¥27,316M | ¥29,678M | ¥33,253M |
| Total Liabilities | ¥28,046M | ¥35,520M | ¥55,489M | ¥64,801M |
| Cash | ¥4,120M | ¥8,256M | ¥7,533M | ¥15,835M |
| Interest-bearing Debt | ¥21,452M | ¥26,719M | ¥43,544M | ¥52,533M |
| Equity Ratio | 29.44% | 43.47% | 34.85% | 33.91% |
| D/E Ratio | 1.83 | 0.98 | 1.47 | 1.58 |
| Cash Flow | ||||
| Operating CF | ¥2,357M | ¥4,156M | ¥2,503M | ¥5,706M |
| Investing CF | -¥6,682M | -¥14,746M | ¥4,450M | -¥3,420M |
| Financing CF | ¥3,972M | ¥14,373M | -¥7,599M | ¥5,957M |
| Free CF | -¥3,226M | -¥747M | -¥3,084M | -¥1,034M |
| Efficiency | ||||
| ROE | 20.70% | 9.50% | 10.55% | 8.58% |
| ROA | 6.10% | 4.13% | 3.68% | 2.91% |
Latest IR Information
-
Notice Regarding Completion of Non-Participation Agreement for Public Tender Offer on Investment Securities
The company will not participate in the public tender offer for HYUGA PRIMARY CARE shares by tendering 840,000 shares. Subsequently, some shares will be sold and/or applied to the target's own tender offer, with a plan to complete a share...
Read more -
[C.U.S.] Q1 2027 Financial Results | Revenue: 14,159 million Yen (+9.0%)
In the first quarter of FY2027 ending March 2027, revenue reached 14,159 million Yen (up 9.0% YoY), but operating profit was only 32 million Yen (down 95.7%), resulting in a net loss. Segments such as Medical Institutions and Hospice achieved...
Read more -
Unknown
Financial results announcement for the first quarter of the fiscal year ending March 2026 shows revenue of approximately 1,415.9 billion yen (up 9.0% YoY), with increases in EBITDA and net profit. Includes detailed analysis by segment and graphical data.
Read more -
Information Regarding Related Parties and Major Shareholders
Read more -
Matters Concerning Controlling Shareholders, etc.
Read more
Latest News (5 items)
-
Average Analyst Rating: none
Average Target Price: ¥900
Rating Score: 3.00 (Based on 1 analysts)
※1=Strong Buy, 5=Strong Sell
Company Information
About
CUC Inc. offers healthcare services in Japan and internationally. It provides medical institution operations support, including strategic, administrative, marketing, HR/recruiting, and procurement support, as well as support for IT, accounting, general affairs, etc.; medical institution revenue growth assistance services, such as M and A, post-merger integration, hospital bed conversion, and clinic launches; and medical institution cost optimization support. The company also provides meals to hospitals, welfare facilities, and hospice facilities; and leases and maintains real estate for medical institutions. In addition, it operates a hospice specializing in care for people in the terminal stages of cancer or with intractable diseases, as well as a home nursing and care business under the ReHOPE brand name. Further, the company offers home nursing; day care services, in-home nursing care support; and in-home clinical trials and in-home monitoring services. The company provides its support service to in-home, hospital, dialysis, and outpatient care. The company was incorporated in 2014 and is headquartered in Minato, Japan. CUC Inc. is a subsidiary of M3 Inc.
